Skip to content

Clinical trials

Phase 3 Lymphoma, B-Cell trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell Phase: Phase 3 Country / region: Belgium Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20111
20131
20191
20201
20213
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting4
Completed4
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Loxo Oncology, Inc.4
Acerta Pharma BV1
Gustave Roussy, Cancer Campus, Grand Paris1
Janssen Research & Development, LLC1
Millennium Pharmaceuticals, Inc.1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell9
Lymphoma, Non-Hodgkin7
Hematologic Diseases4
Lymphoma4
Leukemia, Lymphocytic, Chronic, B-Cell3
Lymphoma, Large B-Cell, Diffuse3
Burkitt Lymphoma1
Leukemia, B-Cell1
Leukemia, Lymphoid1
Lymphatic Diseases1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.